MENLO PARK, Calif.,
Sept. 22, 2015 /PRNewswire/ -- As the
public focuses on breast health in advance of Breast Cancer
Awareness Month, newly released survey results find that most
American women endure breast discomfort during their menstrual
years, but do not know how to treat it or improve the health of
their breasts.
Breast pain, a medical condition known as mastalgia, is
typically caused by fibrocystic breast condition (FBC), which can
cause soreness ranging from mild tenderness to severe pain that
makes it difficult for affected women to even hug a loved one.
The survey, conducted by Harris Poll for specialty
pharmaceutical company BioPharmX Corporation (NYSE MKT: BPMX),
found that 68 percent of women between 25 and 45 years of age
experience premenstrual breast discomfort. Nearly one in five (18
percent) of women in this age range report they suffer "most
months." And 45 percent do not believe there is an effective way to
alleviate the pain from this widespread problem.
The survey also found that 55 percent of women age 25 or older
believe there is a link between breast cancer and breast density,
which often results from FBC. Moreover, 61 percent of women in this
age range do not believe there is any effective solution for
reducing breast density and 48 percent do not believe there is any
effective solution for alleviating premenstrual breast
discomfort
"American doctors have done a great job educating women on the
importance of early detection of breast cancer. The survey
findings show that we can do a better job of educating them about
breast health in general and what they can do to improve it," said
Dr. Lisa Masterson, OB/GYN and
co-host of "The Doctors." "Molecular iodine supplements can help
women to improve their own breast health and reduce the symptoms of
menstrual-related breast tenderness, swelling, aches and
heaviness.
"In most cases, these symptoms will improve noticeably within 60
days of starting a daily molecular iodine regimen, such as
supplements that are available without a prescription," she said.
"Clinical research involving more than 1,300 patients has shown
that up to 74 percent of women experienced improvement in their
breast discomfort."
The BioPharmX survey found that some women who experience breast
discomfort use over-the-counter analgesics. The top three
treatments identified in the survey are ibuprofen (cited by 30
percent of women age 25 and over), massages (13 percent) and
acetaminophen (11 percent).
"It's unfortunate that many women, who likely already take
vitamins and supplements for a variety of health benefits do not
know that molecular iodine supplements may significantly improve
the health of their breasts by reducing fibrocystic breast tissue
and the symptoms of mastalgia," said Dr. Masterson. "Taking one
pill a day can help to end the discomfort and improve breast
health."
BioPharmX, a Silicon Valley specialty pharmaceutical company,
manufactures Violet®, a daily, non-prescription, non-hormone
molecular iodine supplement to promote breast health and alleviate
premenstrual breast discomfort. It is available at select retailers
nationwide and online.
About the Survey
The survey was conducted online within the United States between July 31 and August 5, 2015, among 985
U.S. women ages 25 and older, among whom 400 are age 25-45, by
Harris Poll on behalf of BioPharmX Corporation via its Quick Query
omnibus product. Figures for age, sex, race/ethnicity, education,
region and household income were weighted where necessary to bring
them into line with their actual proportions in the population.
Propensity score weighting was used to adjust for respondents'
propensity to be online.
All sample surveys and polls, whether or not they use
probability sampling, are subject to multiple sources of error
which are most often not possible to quantify or estimate,
including sampling error, coverage error, error associated with
nonresponse, error associated with question wording and response
options, and post-survey weighting and adjustments. Therefore, the
words "margin of error" are avoided as they are misleading. All
that can be calculated are different possible sampling errors with
different probabilities for pure, unweighted, random samples with
100 percent response rates. These are only theoretical because no
published polls come close to this ideal.
Respondents for this survey were selected from among those who
have agreed to participate in our surveys. The data have been
weighted to reflect the composition of the adult population.
Because the sample is based on those who agreed to participate in
the online panel, no estimates of theoretical sampling error can be
calculated.
About BioPharmX Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based
specialty pharmaceutical company, which seeks to provide products
through proprietary platform technologies for prescription,
over-the-counter (OTC), and supplement applications in the health
and wellness markets, including women's health and dermatology. To
learn more about BioPharmX, visit www.BioPharmX.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/survey-shows-most-us-women-suffer-from-premenstrual-breast-discomfort-300146684.html
SOURCE BioPharmX